The change in gene expression in TFAP2A after cetuximab treatment is significantly associated with the observed change in EGFR expression in all HNSCC cell lines (unadjusted LIMMA p-value of 0.001, Figure 5B). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.